[Use of phosphaden in treating chronic ischemic heart disease].
The pharmacodynamics and pharmacotherapy of phosphaden (adenosine-5-monophosphate), a Soviet activator of energy metabolism, were studied in patients with chronic ischemic heart disease. Functional and biochemical methods were used. It was established that phosphaden is an effective drug in the treatment of chronic ischemic heart disease. The results of clinical, functional and biochemical examination support this conclusion.
D000249:Adenosine Monophosphate / Q000008:administration & dosage / Q000627:therapeutic use*; D000328:Adult; D000368:Aged; D000787:Angina Pectoris / Q000188:drug therapy; D002908:Chronic Disease; D003327:Coronary Disease / Q000097:blood / Q000188:drug therapy*; D004341:Drug Evaluation; D004734:Energy Metabolism / Q000187:drug effects; D005260:Female; D006801:Humans; D007273:Injections, Intramuscular; D008297:Male; D008875:Middle Aged; D013997:Time Factors
D000249:Adenosine Monophosphate
Primenenie fosfadena pri lechenii bol'nykh khronicheskoĭ ishemicheskoĭ bolezn'iu serdtsa.